A reader looking for Joi Women’s Wellness now encounters the combined Joi + Blokes website. Its hormone program combines laboratory testing, clinician visits, coaching and separately priced medicines. That creates several linked purchases rather than one self-explanatory estrogen price.
We reviewed the current homepage, hormone product page and a separate HRT offer page on September 28, 2026. We did not order tests or enter treatment. The analysis follows the charges and clinical responsibilities while keeping contradictory public wording visible instead of selecting whichever version sounds simplest.
Joi documents estrogen prescribing, but the selected product’s regulatory status, initial laboratory charge and quarterly commitment need written clarification.
The current identity includes a real estrogen offering
The Joi + Blokes homepage describes medical-history review by partner providers and says estrogen and progesterone prescriptions may be sent to a local pharmacy. The hormone product page specifically lists systemic and vaginal estrogen formats. Together, these establish an actual offering under the current brand, rather than relying on older publicity about Joi’s launch.
The broader website also sells other therapies and laboratory panels. Their presence does not establish that they are appropriate components of menopause treatment. The review focuses on the estrogen pathway and asks which clinician and pharmacy would be involved. National telehealth language should still be checked against the selected treatment and the patient’s location, not interpreted as unrestricted access to the entire catalog.
The care price and medicine price are separate
The product page displays continuing care at $50 per month, billed quarterly, with medications billed separately. It lists systemic estrogen capsules at $49 per month, cream at $69 and patches at $129; vaginal cream and suppositories have their own $69 and $89 monthly displays. These are product-category prices, not interchangeable preparations or an individualized quote.
The same page says shipments and billing occur quarterly. Keep that interval alongside the monthly figures rather than treating them as monthly payment authorizations. If progesterone or another medicine is proposed, it adds another prescription record. Compare this structure with Winona’s product-linked subscription or Pandia’s separate membership and medication charges, while requesting the complete selected transaction from each.
The initial laboratory purchase is not fully explained by ongoing care
Joi’s current product page displays three initial laboratory panel prices: $149, $399 and $699, with a new-customer promotion shown separately. It then describes ongoing labs and clinical visits within the care program. One section refers to all labs; another specifically refers to follow-up labs. The page does not make every initial-charge relationship unambiguous.
A separate HRT offer page displays a different laboratory promotion and discounted figures. Those offer-specific records should not be mixed into an invented universal price. Ask which promotion applies, whether the initial panel is separately charged and which repeat testing is included. Purchasing a larger panel is not evidence of a better estrogen decision, and this review does not recommend testing or interpret laboratory results.
Membership and cancellation wording need reconciliation
The product page contains a no-membership statement and says a subscription can be cancelled at any time. Elsewhere, its price explanation says cancellation is available after the first three months. The homepage’s general fee comparison also presents zero membership and consultation fees, which cannot replace the hormone program’s more specific recurring-care description.
These differences warrant a written agreement identifying the initial commitment, billing dates, included visits and cancellation effect. They do not establish wrongdoing, nor should they be silently harmonized by a reviewer. Thrivelab’s review offers another example of why care fees and medication payments need separate definitions. We did not test Joi’s checkout, refunds or cancellation, so no claim of a frictionless exit is made here.
Bioidentical does not identify the finished preparation
Joi’s hormone page says some supplied drugs may be compounded and not FDA-approved. It also offers several hormone routes without establishing the exact manufacturer and regulatory status of every potential prescription. A category name such as systemic estrogen or a photograph marked as an illustration cannot identify the product that would be dispensed.
FDA’s compounding explanation distinguishes compounded preparations from drugs reviewed for approval. Its menopause guidance also explains that chemically body-identical hormones can occur in approved products. Use patch versus pill to prepare route questions and local versus systemic estrogen to clarify the intended symptom. Neither plant origin nor customization demonstrates superior safety or effectiveness.
A coach is not the prescribing clinician
Joi’s homepage FAQ describes coaches as support contacts and liaisons, and explicitly says they cannot prescribe, diagnose or provide specific medical advice. The hormone program separately lists clinician visits. Ask how a new medical concern reaches the responsible practitioner and when another clinical encounter or local examination is required.
The site’s broad prevention and optimization claims are not used here as proof that estrogen prevents cardiovascular disease, cognitive decline or aging. FDA’s patient guidance says hormone therapy should not be used to prevent heart attacks, strokes or memory loss. Patient stories and the displayed survey area also do not establish comparative treatment outcomes. They cannot replace a discussion of the exact indication, risks and follow-up.
A pharmacy choice changes the purchasing arrangement
The homepage says some estrogen and progesterone prescriptions can go to a local pharmacy where insurance may be used, while Joi does not directly bill insurance. The separate offer page describes a $35 fee per three-month prescription for that route. Confirm whether that fee applies to the chosen current offer and what other care charges remain.
A usable plan should therefore name the medication, dispensing pharmacy, initial laboratory charge, care payment and recurring commitment. The questions-before-starting guide helps keep the clinical conversation beside that purchase record. Joi’s public materials establish a service to investigate, not a verified total, guaranteed coverage or personal hormone recommendation. The unresolved wording should be answered before a reader treats the program as a settled agreement.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- Joi + Blokes: current service and support roles ↗Current provider homepage; coach limits, pharmacy insurance route and generic fee claims separately scoped · Checked 2026-09-28
- Joi + Blokes: hormone care product record ↗Provider care and medicine prices; quarterly units, initial-lab uncertainty and cancellation wording differences retained · Checked 2026-09-28
- Joi + Blokes: separate HRT offer ↗Separate provider offer; different lab promotion and local-pharmacy prescription fee not merged into universal terms · Checked 2026-09-28
- FDA: Understanding the Risks of Compounded Drugs ↗Federal regulatory explanation of compounded drug approval limits; no inference about a particular pharmacy inspection · Checked 2026-09-28
- FDA: Menopause ↗Current federal patient guidance; individualized benefits/risks and prevention limits, no class-wide labeling-change inference · Checked 2026-09-28